Cargando…

Antimicrobial proteins and polypeptides in pulmonary innate defence

Inspired air contains a myriad of potential pathogens, pollutants and inflammatory stimuli. In the normal lung, these pathogens are rarely problematic. This is because the epithelial lining fluid in the lung is rich in many innate immunity proteins and peptides that provide a powerful anti-microbial...

Descripción completa

Detalles Bibliográficos
Autores principales:	Rogan, Mark P, Geraghty, Patrick, Greene, Catherine M, O'Neill, Shane J, Taggart, Clifford C, McElvaney, Noel G
Formato:	Texto
Lenguaje:	English
Publicado:	BioMed Central 2006
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1386663/ https://www.ncbi.nlm.nih.gov/pubmed/16503962 http://dx.doi.org/10.1186/1465-9921-7-29

Ejemplares similares

Respiratory epithelial cells require Toll-like receptor 4 for induction of Human β-defensin 2 by Lipopolysaccharide
por: MacRedmond, Ruth, et al.
Publicado: (2005)

Quantification and Evaluation of the Role of Antielastin Autoantibodies in the Emphysematous Lung
por: Low, Teck Boon, et al.
Publicado: (2011)

Secretory leucoprotease inhibitor binds to NF-κB binding sites in monocytes and inhibits p65 binding
por: Taggart, Clifford C., et al.
Publicado: (2005)

Inhibition of Toll-Like Receptor 2-Mediated Interleukin-8 Production in Cystic Fibrosis Airway Epithelial Cells via the α7-Nicotinic Acetylcholine Receptor
por: Greene, Catherine M., et al.
Publicado: (2010)

The Ability of Secretory Leukocyte Protease Inhibitor to Inhibit Apoptosis in Monocytes Is Independent of Its Antiprotease Activity
por: McGarry, Niamh, et al.
Publicado: (2015)

Epithelial expression of TLR4 is modulated in COPD and by steroids, salmeterol and cigarette smoke
por: MacRedmond, Ruth E, et al.
Publicado: (2007)

Intracellular Secretory Leukoprotease Inhibitor Modulates Inositol 1,4,5-Triphosphate Generation and Exerts an Anti-Inflammatory Effect on Neutrophils of Individuals with Cystic Fibrosis and Chronic Obstructive Pulmonary Disease
por: Reeves, Emer P., et al.
Publicado: (2013)

Aspergillus-Associated Airway Disease, Inflammation, and the Innate Immune Response
por: Chotirmall, Sanjay H., et al.
Publicado: (2013)

Isolation and identification of cell-specific microRNAs targeting a messenger RNA using a biotinylated anti-sense oligonucleotide capture affinity technique
por: Hassan, Tidi, et al.
Publicado: (2013)

Is There a Therapeutic Role for Selenium in Alpha-1 Antitrypsin Deficiency?
por: Greene, Catherine M., et al.
Publicado: (2013)

Characterisation of the Major Extracellular Proteases of Stenotrophomonas maltophilia and Their Effects on Pulmonary Antiproteases
por: Molloy, Kevin, et al.
Publicado: (2019)

Gene targeted therapeutics for liver disease in alpha-1 antitrypsin deficiency
por: McLean, Caitriona, et al.
Publicado: (2009)

MicroRNAs in inflammatory lung disease - master regulators or target practice?
por: Oglesby, Irene K, et al.
Publicado: (2010)

Lung involvement at presentation predicts disease activity and permanent organ damage at 6, 12 and 24 months follow - up in ANCA - associated vasculitis
por: Hassan, Tidi M, et al.
Publicado: (2014)

Diagnosing α(1)-antitrypsin deficiency: how to improve the current algorithm
por: McElvaney, Noel G.
Publicado: (2015)

Hypertonic Saline in Treatment of Pulmonary Disease in Cystic Fibrosis
por: Reeves, Emer P., et al.
Publicado: (2012)

Alpha-1 antitrypsin augmentation therapy decreases miR-199a-5p, miR-598 and miR-320a expression in monocytes via inhibition of NFκB
por: Hassan, Tidi, et al.
Publicado: (2017)

Interleukin-6: obstacles to targeting a complex cytokine in critical illness
por: McElvaney, Oliver J, et al.
Publicado: (2021)

Airway inflammatory markers in individuals with cystic fibrosis and non-cystic fibrosis bronchiectasis
por: Bergin, David A, et al.
Publicado: (2013)

Reply to Blot et al. and to Inoue et al.
por: McElvaney, Oliver J., et al.
Publicado: (2021)

miRNA-221 is elevated in cystic fibrosis airway epithelial cells and regulates expression of ATF6
por: Oglesby, Irene K, et al.
Publicado: (2015)

Impaired Airway Epithelial Barrier Integrity in Response to Stenotrophomonas maltophilia Proteases, Novel Insights Using Cystic Fibrosis Bronchial Epithelial Cell Secretomics
por: Molloy, Kevin, et al.
Publicado: (2020)

Altered Degranulation and pH of Neutrophil Phagosomes Impacts Antimicrobial Efficiency in Cystic Fibrosis
por: Hayes, Elaine, et al.
Publicado: (2020)

Targeting IgG Autoantibodies for Improved Cytotoxicity of Bactericidal Permeability Increasing Protein in Cystic Fibrosis
por: McQuillan, Karen, et al.
Publicado: (2020)

Cystic fibrosis disease severity correlates with plasma levels of desmosine and isodesmosine, biomarkers of elastin degradation
por: Ma, Shuren, et al.
Publicado: (2019)

Innate immune defences in the human endometrium
por: King, Anne E, et al.
Publicado: (2003)

Latest advances in innate antiviral defence
por: Irving, Aaron, et al.
Publicado: (2009)

miR-224-5p and miR-545-5p Levels Relate to Exacerbations and Lung Function in a Pilot Study of X-Linked MicroRNA Expression in Cystic Fibrosis Monocytes
por: McKiernan, Paul J., et al.
Publicado: (2021)

Activation of complement component 3 is associated with airways disease and pulmonary emphysema in alpha-1 antitrypsin deficiency
por: O'Brien, Michael E, et al.
Publicado: (2020)

Alpha-1 antitrypsin for cystic fibrosis complicated by severe cytokinemic COVID-19
por: McElvaney, Oliver J, et al.
Publicado: (2021)

Neutrophil Membrane Cholesterol Content is a Key Factor in Cystic Fibrosis Lung Disease
por: White, Michelle M., et al.
Publicado: (2017)

The role of TIM-containing molecules in airway disease and their potential as therapeutic targets
por: Vega-Carrascal, Isabel, et al.
Publicado: (2012)

Alpha-1 antitrypsin regulates neutrophil reactive oxygen species production via inhibition of key players of the respiratory burst oxidase system
por: Alfawaz, Bader, et al.
Publicado: (2013)

Editorial: Novel Anti-Inflammatory Approaches for Cystic Fibrosis Lung Disease: Identification of Molecular Targets and Design of Innovative Therapies
por: Ribeiro, Carla Maria Pedrosa, et al.
Publicado: (2021)

The prevalence of alpha-1 antitrypsin deficiency in Ireland
por: Carroll, Tomás P, et al.
Publicado: (2011)

Dysregulated plasma lipid mediator profiles in critically ill COVID-19 patients
por: Palmas, Francesco, et al.
Publicado: (2021)

A linear prognostic score based on the ratio of interleukin-6 to interleukin-10 predicts outcomes in COVID-19
por: McElvaney, Oliver J, et al.
Publicado: (2020)

Corrigendum to ‘A linear prognostic score based on the ratio of interleukin-6 to interleukin-10 predicts outcomes in COVID-19’
por: McElvaney, Oliver J, et al.
Publicado: (2020)

Exploring the views of healthcare professionals on increasing smoking cessation advice for patients
por: Ho, ShuYing, et al.
Publicado: (2013)

Dysregulated neutrophil function in individuals with alpha-1 antitrypsin deficiency caused by modified membrane cholesterol content.
por: Jundi, Bakr, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_675voviv38suh7b169qu7ljp98